Bo Abrahamsen MD, PhD

Bo Abrahamsen, MD, Ph.D. is a consultant endocrinologist at Hospital Gentofte, Copenhagen, professor of clinical database studies at the University of Southern Denmark, and President of the Danish Bone Society. He attended medical school at Odense University, Denmark, and the BSc Honours course in experimental pathology at St. Andrews, qualifying as a physician in 1990. He did the clinical work for his Ph.D. at Odense University Hospital and the laboratory work with Sandy C. Marks, Jr. at UMASS Medical School, Worcester, MA in 1995.

Dr. Abrahamsen was appointed consultant endocrinologist in 2005 and professor in 2009. His main research interests are absolute fracture risk, fracture epidemiology, rational targeting of anti-osteoporotic therapy, adherence to therapy, and not least safety of anti-osteoporotic drugs and supplements. Other research interests include the RANKL/OPG system, osteoporosis genetics, gene-environment interaction, male osteoporosis, and personalized osteoporosis therapy.